Alivus Life Sciences Ltd (ALIVUS) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Granules India

Alivus Life

Sanofi Consumer

Caplin Point Lab

Cohance Life

Alembic Pharma

Concord Biotech

Jubilant Pharmo

OneSource Speci.

Rubicon Research

Corona Remedies

Why is Alivus Life Sciences Ltd ?

High Management Efficiency with a high ROE of 18.73%

Company has a low Debt to Equity ratio (avg) at 0 times

Poor long term growth as Net Sales has grown by an annual rate of 4.88% and Operating profit at 4.00% over the last 5 years

Positive results in Dec 25

NET SALES(Q) Highest at Rs 672.89 cr
PBDIT(Q) Highest at Rs 231.28 cr.
OPERATING PROFIT TO NET SALES(Q) Highest at 34.37%

With ROE of 18.7, it has a Fair valuation with a 4.2 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 11.18%, its profits have risen by 27.5% ; the PEG ratio of the company is 0.8

Majority shareholders : Promoters

Consistent Returns over the last 3 years

Along with generating 11.18% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Alivus Life should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Alivus Life for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Alivus Life

11.37%

0.40

28.34%

Sensex

3.82%

0.29

13.55%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.88%

EBIT Growth (5y)

4.00%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.20

Sales to Capital Employed (avg)

1.10

Tax Ratio

25.19%

Dividend Payout Ratio

12.62%

Pledged Shares

Institutional Holding

12.21%

ROCE (avg)

37.18%

ROE (avg)

18.73%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.23

EV to EBIT

17.13

EV to EBITDA

15.57

EV to Capital Employed

5.02

EV to Sales

4.84

PEG Ratio

0.83

Dividend Yield

0.48%

ROCE (Latest)

27.80%

ROE (Latest)

18.68%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

NET SALES(Q)

Highest at Rs 672.89 cr

PBDIT(Q)

Highest at Rs 231.28 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 34.37%

PBT LESS OI(Q)

At Rs 210.12 cr has Grown at 25.6% (vs previous 4Q average

PAT(Q)

At Rs 169.69 cr has Grown at 28.0% (vs previous 4Q average

EPS(Q)

Highest at Rs 12.25

-1What is not working for the Company

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 19.18 cr

Loading Valuation Snapshot...

Here's what is working for Alivus Life

Net Sales - Quarterly

Highest at Rs 672.89 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 231.28 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Highest at 34.37%

in the last five quarters

MOJO Watch

Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 210.12 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 210.12 cr has Grown at 25.6% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 167.33 Cr

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 169.69 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 169.69 cr has Grown at 28.0% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 132.60 Cr

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 12.25

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Alivus Life

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 19.18 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents